Try our beta test site

The Effect of Liraglutide on the Treatment of Coronary Artery Disease and Type 2 Diabetes (AddHope2)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Haugaard, Steen Bendix, M.D., DMSc
ClinicalTrials.gov Identifier:
NCT01595789
First received: May 8, 2012
Last updated: July 29, 2015
Last verified: July 2015